Dr. Stavros Stavrakis, MD

Dr. Stavrakis practices at Ou Medical Center-The Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma.

Dr. Stavrakis' NPI, 1467593152, was assigned on February 8, 2007. Dr. Stavrakis graduated from University of Oklahoma College of Medicine in 2011. Dr. Stavrakis holds Oklahoma license 24491.

Dr. Stavrakis' primary practice is Ou Medical Center-the Children's Ho - Rad CT - HOPD, at 1200 Childrens Ave, Oklahoma City, OK 73104.

Dr. Stavrakis' primary practice is Ou Medical Center-The Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma. Dr. Stavrakis is also affiliated with OU Health University of Oklahoma Medical Center. The medical group on file is OU Health. Dmand AI also links Dr. Stavrakis to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stavrakis practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Stavrakis' primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Stavrakis is licensed in Oklahoma.

CMS data shows 380 Medicare services from Dr. Stavrakis across 13 procedure codes in 2024, for 184 Medicare patients. Medicare paid $23,058 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 184 Medicare patients who saw Dr. Stavrakis in 2024. The largest group is 65 to 74, with 66 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Stavrakis' median patient age at 71, with 56% women.

In 2024, Dr. Stavrakis wrote 764 Medicare Part D claims for 117 patients. 70% of them were for generic drugs. CMS names the drug for 612 of them, across 21 drugs with 11 or more claims each, at $263,495 in total drug cost. In 2023, CMS named 632 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 77 out of 100 for Dr. Stavrakis for performance year 2024, reported as part of a group. Dr. Stavrakis accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 189 papers to Dr. Stavrakis, published from 2010 to 2025. 2023 was the busiest year, with 33. The most frequent topics are Atrial Fibrillation, Electrocardiography and Catheter Ablation. Dr. Stavrakis has published most often in J Interv Card Electrophysiol. Dr. Stavrakis' most frequent co-authors are Sunny S. Po, MD, Christopher V. Desimone and Muhammad Munir, MD.

Dmand AI links Dr. Stavrakis to 3 clinical trials. Conditions studied include Atrial Fibrillation, Inflammation and Arrhythmias, Cardiac. University of Oklahoma sponsors the most, 2.

CMS Open Payments shows 97 general payments to Dr. Stavrakis from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 47% of the total. Medtronic Vascular, Inc. paid the most, $3,276.

Dr. Stavrakis graduated from University of Oklahoma College of Medicine in 2011.